AI assistant
Sending…
EXELIXIS, INC. — Director's Dealing 2024
Nov 20, 2024
30561_dirs_2024-11-19_e0a46237-9fd8-45fd-879c-0973fc506f2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-11-15
Reporting Person: Peterson Amy C. (EVP Prod Dev & Med Aff & CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-15 | Common Stock | F | 27224 | $35.05 | Disposed | 294897 | Direct |
Footnotes
F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded August 24, 2023.
F2: Includes 262,121 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Common Stock.
More from EXELIXIS, INC.
Regulatory Filings
2026
May 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 21